Health + Life Science


The Health + Life Science industries are facing a perfect storm of converging forces that are upending established structures and are reshaping the way companies compete and grow.

Convergence brings with it significant strategic implications for participants in the Healthcare and Life industries involved – both for industry incumbents and new entrants. Fuld & Company partners with clients in the pharmaceutical, biotechnology, medical devices, healthcare provider, and payer sectors to deliver a blend of health + life science consulting services help them bridge the gap between their business today and a vision for the future.

We are a unique health + life science consulting firm, focused on supporting competitive strategy through a blend of research, analysis and strategy services.

By employing a number of sophisticated methodologies that produce a holistic external market view, Fuld & Company health + life science consulting services help clients navigate through the disruption and create robust and concrete strategies to:

  • Understand and implement advanced technology, data, and innovation.
  • Adapt products, services, and processes to the changing dynamics of the end-user.
  • Outpace both traditional competitors and new entrants.
  • Understand key factors and grow in a globalized marketplace.
  • Maximize product launches and optimize lifecycle management.
  • Anticipate and address shifting policy changes and the move towards a value-based system.
  • Explore the right alliances and acquisitions.

Download our White Paper: Healthcare Scenarios in a Trump World

Interested in how our competitive strategy health + life science consulting services can help you grow and compete?


Early Warning Toolkit

You may also be interested in

Read More

2019 Pharma Companies to Watch Report

Read More

Targeting Regional Growth Opportunities for Medical Devices Companies

Read More

Planning for the Unpredictable, The Future of Healthcare: The Shifting Burden of Risk

Read More

Identifying Promising Pharma Licensing Candidates

Subscribe to our mailing list for our latest updates: